Crinetics Pharmaceuticals Ownership | Who Owns Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals Ownership Summary
Crinetics Pharmaceuticals is owned by 111.46% institutional investors, 2.02% insiders. Vanguard group is the largest institutional shareholder, holding 11.35% of CRNX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.13% of its assets in Crinetics Pharmaceuticals shares.
CRNX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Crinetics Pharmaceuticals | 111.46% | 2.02% | -13.48% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 9.09M | 11.35% | $464.74M |
| Fmr | 8.93M | 11.15% | $456.49M |
| Wellington management group llp | 6.95M | 8.68% | $355.38M |
| Blackrock | 6.23M | 8.62% | $279.06M |
| Blackrock funding, inc. /de | 7.42M | 7.91% | $213.36M |
| Driehaus capital management | 6.40M | 6.82% | $184.06M |
| Price t rowe associates inc /md/ | 5.41M | 6.76% | $276.84M |
| Ecor1 capital | 4.29M | 5.35% | $219.25M |
| Farallon capital management | 4.65M | 4.95% | $133.62M |
| State street | 2.99M | 3.73% | $152.92M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ecor1 capital | 4.29M | 8.29% | $219.25M |
| New leaf venture partners | 141.00K | 7.66% | $4.06M |
| Paradigm biocapital advisors lp | 1.91M | 3.40% | $97.70M |
| Ghost tree capital | 240.00K | 3.37% | $10.75M |
| First light asset management | 864.14K | 3.22% | $24.85M |
| Novo | 1.55M | 3.15% | $44.58M |
| Siren | 1.69M | 2.51% | $48.56M |
| Ikarian capital | 433.43K | 2.39% | $12.47M |
| Vestal point capital, lp | 1.50M | 2.27% | $43.14M |
| Bioimpact capital | 428.98K | 2.14% | $12.34M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 8.93M | 0.03% | 4.47M |
| Vanguard group | 9.09M | 0.01% | 2.80M |
| Wellington management group llp | 6.95M | 0.07% | 2.49M |
| Point72 asset management | 2.00M | 0.11% | 1.22M |
| Blackrock | 6.23M | 0.01% | 794.27K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Lord, abbett | - | - | -724.63K |
| Eventide asset management | - | - | -609.01K |
| Paradigm biocapital advisors lp | 1.91M | 3.40% | -605.92K |
| First turn management | - | - | -453.38K |
| Dimensional fund advisors lp | - | - | -392.20K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Rtw investments, lp | 467.00K | 0.19% | 467.00K | $13.43M |
| Prosight management, lp | 298.12K | 2.09% | 298.12K | $8.57M |
| Baker bros. advisors lp | 280.00K | 0.08% | 280.00K | $8.05M |
| Segall bryant & hamill | 150.40K | 0.11% | 150.40K | $7.69M |
| Xtx topco | 34.01K | 0.04% | 34.01K | $978.21K |
Sold Out
| Holder | Change |
|---|---|
| Corecap advisors | -7.00 |
| Capital performance advisors llp | -8.00 |
| Northwestern mutual wealth management | -16.00 |
| Householder group estate & retirement specialist | -25.00 |
| Continuum advisory | -25.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 219 | -2.67% | 104,541,979 | 7.66% | 111 | 1.02% | 129 | 3.20% | 64 | -11.11% |
| Mar 31, 2025 | 227 | -8.84% | 101,882,125 | 2.21% | 109 | 0.71% | 125 | -15.54% | 72 | 9.09% |
| Dec 31, 2024 | 243 | 2.53% | 99,207,040 | 17.39% | 123 | 1.11% | 144 | 18.03% | 66 | -12.00% |
| Sep 30, 2024 | 235 | -1.67% | 84,500,757 | 2.47% | 105 | 0.81% | 121 | -20.91% | 74 | 37.04% |
| Jun 30, 2024 | 239 | 8.64% | 82,467,822 | 2.56% | 114 | 0.92% | 153 | 20.47% | 54 | -3.57% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.95M | 3.13% | -62.07K |
| Vanguard US Total Market Shares ETF | 2.40M | 2.58% | 2.45K |
| Vanguard Small Cap Index | 2.27M | 2.41% | -15.07K |
| Fidelity OTC | 2.18M | 2.32% | 491.00 |
| iShares Russell 2000 ETF | 2.12M | 2.25% | -40.32K |
| US Small-Cap Growth II Equity Comp | 2.06M | 2.20% | -58.41K |
| T. Rowe Price New Horizons | 2.06M | 2.20% | 136.71K |
| Vanguard Health Care Inv | 1.32M | 1.41% | -961.79K |
| T. Rowe Price Integrated US SmCapGrEq | 1.28M | 1.38% | 722.20K |
| Fidelity Select Health Care | 1.28M | 1.37% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 02, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | $160.50K |
| Aug 22, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | $912.90K |
| Aug 20, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | $189.44K |
| Jun 12, 2025 | Betz Stephen F. | Chief Scientific Officer | Sell | $3.14M |
| Mar 19, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | $81.60K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 3 |
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 10 |
| 2024 Q4 | - | 3 |
| 2024 Q3 | - | 11 |
CRNX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools